David Chen
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About David Chen
David Chen is recorded as CEO at Allogene Therapeutics, Inc. (ALLO). David Chen has spoken on 1 investor event across 1 company, most recently for Allogene Therapeutics, Inc. on June 3, 2026.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Allogene Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Zachary Roberts, M.D., Ph.D. CEO, Board Member
- Geoffrey Parker CFO
- Tim Moore CTO
- Timothy Moore CTO
- Annie Yoshiyama Chief Accounting Officer
- Elizabeth Barrett Board Member
- Stephen Mayo, Ph.D. Board Member
- Vicki Sato, Ph.D. Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.